Deep Tech Startups

NTI Fund is a Russian government institution supporting the National Technological Initiative, which develops emerging technology markets and sectors critical to technological leadership and sovereignty. The fund conducts market research, identifies promising technologies and products from Russian producers, organizes technology competitions, and supports unmanned aviation systems and digital health initiatives.

1 investor

NTWIST develops AI-powered software and agentic AI systems that help mining and manufacturing teams optimize industrial operations, connecting to SCADA, MES, ERP, and PLC systems to support decisions from the pit and shop floor to the boardroom. Its products cover predictive modeling, real-time optimization, and intelligent automation for industrial operators, planners, and executives.

1 investor

Nuada builds energy-efficient carbon capture machines using advanced materials science to reduce industrial emissions from hard-to-abate sectors. The company has deployed its technology at commercial scale in cement, biomass incineration, and energy-from-waste applications, achieving 90% improved energy efficiency over existing solutions.

1 investor

Nuance Labs is building an audiovisual "human foundation model" with emotional intelligence that reads tone, expression, and hesitation, and responds in real time. Its full-duplex engine aims to enable natural, face-to-face AI interaction that sees, hears, reasons, speaks, and expresses simultaneously.

1 investor

NUBURU develops high-power industrial blue lasers for welding copper, aluminum, and other metals, as well as additive manufacturing and 3D printing. Its BL and BL-F product lines target manufacturers in energy storage, e-mobility, aerospace, healthcare, and electronics packaging.

1 investor

NucleoTech engineers BrainPortal carrier proteins that attach to therapeutic antibodies and oligonucleotides and transport them across the blood-brain barrier non-invasively, using a direct in vivo screening platform to test many candidates simultaneously. It advances internal CNS therapeutics and licenses its carriers to pharma and biotech partners.

1 investor

Nula Therapeutics develops targeted small-molecule medicines that correct how the nuclear envelope regulates gene expression and cellular function. The company focuses on treating age-related diseases including metabolic dysfunction, neurodegeneration, and cancer, and on extending healthspan.

1 investor

Nulixir appears to be a beverage or wellness product company that formulates drinks with herbal extracts, amino acids, and vitamins. The page shows a board of advisors section featuring Gerry, an experienced executive with extensive background in consumer products, manufacturing, and beverage industry turnarounds.

1 investor

N0 Labs develops an open environment simulation platform that enables robotics and AI teams to accelerate robot development and testing by providing tools for perception and action systems.

1 investor

Numab develops multispecific antibody-based therapeutics using its proprietary λ-Cap and MATCH discovery and engineering platforms, aiming to improve on first-generation antibody therapies in potency, stability, effect duration, and safety. It maintains its own drug pipeline targeting clinically validated pathways and works with pharma and biotech partners on discovery and development.

1 investor

Numascale designs node controller chips that enable servers to scale from 8 to 32 CPUs as cache-coherent shared memory systems, targeting enterprise high-performance computing workloads. Their UNC5 product powers scale-up servers from manufacturers including Eviden, Dell, and Hitachi for applications like SAP HANA and OLAP analytics.

1 investor

Numenos builds patient-centric biological world models that learn from individual patient data across all diseases to discover the causal mechanisms underlying human biology. The platform applies machine learning to biology with the aim of enabling individualized treatments.

1 investor

Numenta develops artificial intelligence systems based on neocortical principles derived from neuroscience research, designed to continuously learn and adapt with greater efficiency than conventional AI. The company serves developers, researchers, and organizations seeking machine intelligence capable of handling complex, real-world challenges across diverse domains.

1 investor

Nutromics is developing a "lab-on-a-patch" that combines DNA-based (EAB) sensors with microneedles to continuously monitor multiple targets in the body for diagnostic and treatment use. The technology aims to provide real-time trend data for dynamic targets and fast-moving conditions; the product is still in development and not yet approved by regulators.

1 investor

NUUV develops water management products and services aimed at improving efficiency, control, and insight into water usage. The company applies UV LED treatment technology and engineering expertise to water and infrastructure applications.

1 investor

Nuvola develops SafeCoat, a separator material for lithium-ion batteries designed to improve safety, performance, and manufacturing efficiency. The company serves battery original equipment manufacturers globally with its advanced coating technology.

1 investor

NuXcel is a global medical device accelerator that founds and incubates bioelectronics and neuromodulation startups addressing large unmet clinical needs, using a lean innovation model. Operating with partner Treo Ventures, it has created companies such as ShiraTronics, Avivomed, iVEAcare, and iRiva Medical, with offices in Ireland, Minneapolis, and Silicon Valley.</parameter> <parameter name="founders">[{"full_name": "Mudit K. Jain", "title": "Founder and CEO"}, {"full_name": "Lynn Elliott", "title": "Founder and CTO"}]</parameter> <parameter name="hq_city">Minneapolis

1 investor

CyteType is a cell type annotation tool for single-cell RNA-seq data that provides evidence trails for annotations, Cell Ontology standardization, and disease context handling. It supports multiple deployment options including on-premise and cloud hosting, with deterministic reproducibility for regulatory and QC applications.

1 investor

Nyobolt develops high-power lithium-ion batteries with ultra-fast charging based on niobium tungsten oxide anode materials, delivered as integrated energy storage systems. It targets applications requiring high uptime such as AI data centres, autonomous robotics, commercial and passenger EVs, grid infrastructure, and heavy industrial fleets.

1 investor

A company engineering humanoid robots designed for industrial work, manufactured in Japan and built for global deployment across sectors facing workforce shortages.

1 investor

O/E Land manufactures fiber optic sensors and photonics instruments for industrial and scientific measurement applications. The company provides temperature, humidity, strain, displacement, pressure, and acceleration sensors alongside photonic components and optical analysis systems.

1 investor

Dimericon Therapeutics is a biotech company developing crosslinked helix dimers ("Dimericons") as therapeutics and as templates for small-molecule development, targeting hard-to-drug intracellular protein-protein interactions. Its lead program focuses on hematological malignancies, with a seed round supporting preclinical work toward an IND-ready clinical candidate.

1 investor

Oban Biopharma develops allosteric GPCR-targeted therapeutics for metabolic and CNS/neuropsychiatric diseases, using computational structural and chemotype analysis combined with AI-based druggability filters to identify drug candidates. Its pipeline focuses on allosteric modulators of clinically validated GPCR targets intended to offer efficacy with fewer side effects than traditional orthosteric drugs.

1 investor

NIRSit Lite Kids is a portable, wireless neuroimaging device designed for brain measurement research in children, supporting applications in developmental disorder research, educational assessment, neurofeedback training, and AR/VR effectiveness testing.

1 investor